| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.18B | $2.58B | $2.41B |
| YoY Revenue Growth % | +23.1% | +7.3% | — |
| Gross Profit | $731.1M | $643.8M | — |
| Gross Margin % | 23.0% | 24.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $342.4M | $283.5M | $240.7M |
| Operating Margin % | 10.8% | 11.0% | 10.0% |
| Net Income (GAAP) | $121.5M | $184.0M | $161.5M |
| EBITDA (Normalized) | $457.0M | $350.7M | $327.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $248.7M | $213.3M | $214.6M |
| Capital Expenditures (CapEx) | $143.3M | $84.0M | $108.4M |
| Free Cash Flow (FCF) | $105.4M | $129.3M | $106.2M |
| FCF Margin % | 3.3% | 5.0% | 4.4% |
| Return on Invested Capital (ROIC %) | 16.6% | 18.6% | 7.8% |
| Cash & Short-Term Equivalents | $98.7M | $83.8M | — |
| Total Debt (Short + Long Term) | $608.9M | $435.0M | $950.2M |
| Total Stockholders' Equity | $1.12B | $855.1M | $1.95B |